Lymphoma, extranodal NK-T-cell

Clinical trials for Lymphoma, extranodal NK-T-cell explained in plain language.

Never miss a new study

Get alerted when new Lymphoma, extranodal NK-T-cell trials appear

Sign up with your email to follow new studies for Lymphoma, extranodal NK-T-cell, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet finished but already full! 1

New hope for lymphoma patients who Can't take chemo

Disease control Ongoing

This phase 2 trial is testing whether combining the immunotherapy drug pembrolizumab (Keytruda) with targeted radiation can control a rare type of lymphoma called NK/T-cell lymphoma. It enrolls 30 patients with early-stage disease who are not healthy enough for standard chemother…

Matched conditions: LYMPHOMA, EXTRANODAL NK-T-CELL

Phase 2 • Sponsor: International Extranodal Lymphoma Study Group (IELSG) • Aim: Disease control

Last updated Jun 27, 2026 12:04 UTC

Lymphoma, extranodal NK-T-cell

Get alerted when new Lymphoma, extranodal NK-T-cell trials appear

New hope for lymphoma patients who Can't take chemo